|22.08|| +0.80 / +3.76%|
Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health segments. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. The Consumer Health segment engages in the sales of animal health and over-the-counter (OTC) products, both branded and private label. The company was founded in 1971 and is headquartered in Lake Forest, IL.
|Rajat Rai||Chief Executive Officer|
|Bruce Kutinsky||Chief Operating Officer|
|Duane A. Portwood||CFO & Executive Vice President|
|Mark M. Silverberg||Executive VP-Operations & Technical Services|
|Joseph P. Bonaccorsi||Secretary, Senior Vice President & General Counsel|